Zebrafish ApoB-Containing Lipoprotein Metabolism: A Closer Look

Area of Science:

• Lipid metabolism and cell biology
• Comparative genomics and disease modeling

Background:

• Zebrafish share conserved proteins with mammals, enabling study of human lipoprotein metabolism.
• Mutations in zebrafish genes linked to metabolic diseases often mirror human phenotypes.
• Zebrafish larvae display a transparent yolk, facilitating visualization of lipid dynamics.

Purpose of the Study:

• To review recent research on ApoB-containing lipoproteins and lipid metabolism in zebrafish.
• To summarize new insights into yolk cell lipid processing and its effect on yolk opacity.
• To highlight zebrafish as a model for discovering new players in human lipoprotein-related diseases.

Main Methods:

• Utilizing zebrafish models with gene mutations affecting lipoprotein metabolism (e.g., ldlra, apoC2).
• Observing visible phenotypes like cytoplasmic lipid droplets and yolk opacity.
• Employing techniques to study fluorescently labeled lipid uptake in transparent larvae.
• Investigating in vivo lipoprotein uptake by endothelial cells via STAB receptors.

Main Results:

• Disturbances in lipoprotein formation cause visible lipid droplet accumulation and yolk opacity.
• Zebrafish models have successfully mimicked human metabolic diseases.
• Studies have identified new roles for proteins like MTTP and ApoB in lipid metabolism.
• In vivo descriptions of STAB receptors mediating lipoprotein uptake have been achieved.

Conclusions:

• Zebrafish provide a valuable, visually-driven model for investigating lipoprotein metabolism and related human diseases.
• Yolk opacity serves as a sensitive indicator for disruptions in lipid flux, aiding genetic screens.
• Advancements in zebrafish research facilitate the identification of novel therapeutic targets for metabolic disorders.